AI assistant
Sending…
Edesa Biotech, Inc. — Director's Dealing 2018
Apr 3, 2018
35006_dirs_2018-04-03_ee6c90fb-51ca-41e9-9e06-bfbb6883687f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Stellar Biotechnologies, Inc. (SBOT)
CIK: 0001540159
Period of Report: 2018-03-29
Reporting Person: MORSE DANIEL E. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-29 | Common Shares, without par value | S | 4366 | $0.805 | Disposed | 0 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares, without par value | 194523 | Direct |
More from Edesa Biotech, Inc.
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 2